HU-308, a cannabis substitute, can reduce L-dopa induced dyskinesia in Parkinson's patients.
Researchers have identified the structure of the human type 2 cannabinoid receptor. The findings, researchers say, can help in the development of new treatments for inflammatory and neurodegenerative diseases.
Researchers shed light on the endocannabinoid system and report how cannabis is helping to provide relief to many with medical problems.
A new study reveals how dangerous inflammations in the brain are caused during the aging process. Researchers say failure with the CB1 to control activity of immune cells may result in chronic neuroinflammation. They say it may be possible to break this vicious cycle in the future with drugs that contain THC, which is a powerful CB1 receptor activator.
Researchers report deficiencies of natural cannabinoids could result in a predisposition for developing depression and PTSD. Boosting the system could help in treating stress related disorders.
A new study suggests developing new therapeutics that use cannabinoid receptors to treat chronic pain.
Researchers have created the most detailed 3D structure to date of the brain receptor that binds and responds to the root of the marijuana high.
The findings could provide new insights into brain diseases such as Alzheimer's, schizophrenia and depression.
